AG
alexander giesen
Department of Urology, University Hospitals Leuven
Belgium
Authors
- CW
chaofu wang
Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
China
- DV
diana v. maslov
Department of Hematology/Oncology, Scripps Health System
United States
- FC
frank claessens
Departments of Cellular and Molecular Medicine and Clinical and Experimental Medicine, Catholic University Leuven (KU Leuven)
Belgium
- HT
hisashi tanaka
Department of Surgery, Cedars-Sinai Medical Center
United States
- HZ
huizhi zhang
Department of Pathology, Ningbo Clinical Pathology Diagnosis Center
China
- JC
j. carl barrett
Translational Medicine, Oncology Research and Development (R&D), AstraZeneca
United States
- JP
james p. daniels
Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
United States
- JC
jason cham
Scripps Clinic/Green Hospital, Department of Internal Medicine
United States
- LB
loïc baekelandt
Department of Urology, University Hospitals Leuven
Belgium
- MS
miaomiao shen
Department of Pathology, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College
China
- MR
michael r. freeman
Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
United States
